|
Get Financial Filings and Annual Reports for Companies featured on TWST from EasyReports.net
TWST: Can we start out with an update on Renal Care Group? What has gone
on over the past couple of quarters that investors should focus on?
Mr. Allison: Renal Care is a six-year-old company. Over the last two
quarters, we have been achieving about a 15% earnings per share growth,
which is what our CEO, Sam Brooks, came out and said in September of
last year, that was our three- to five-year target. And that has proven
to be the case. We are very consistent. We have recurring revenues. So I
guess the thing is that we just continue to be a very consistent
earnings performer, and during this same period of time our balance
sheet has continued to strengthen to the point where today we actually
have no debt at all. TWST: That's a good position to be in, I guess, in this environment.
Mr. Allison: It certainly gives you a lot of comfort. One of the things
we want to look at is, how do we effectively utilize debt to give
shareholders a return? But, at this point in time, we have not come up
with an opportunity that we believe is worth investing additional debt
dollars in.
Tickers included in this excerpt: RCI
For more information call (212) 952 7400. The
Wall Street Transcript does not endorse any of the comments made by interviewees, and does
not make stock recommendations.
|
|
 |
